You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-lymphoid

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

Active, not recruiting
  • Recurrent Chronic Lymphoid Leukemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

Completed
Has Results
  • B-cell Lymphoid Malignancies
  • Fort Myers, Florida
  • +14 more
Mar 1, 2022

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide

Recruiting
  • Acute Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Apr 5, 2021

Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

Recruiting
  • Lymphoblastic Leukemia
  • +5 more
  • Anti-CD19 CAR T-cells
  • Singapore, Singapore
  • +1 more
Dec 4, 2022

B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

Not yet recruiting
  • B-All
  • Acute Lymphoblastic Leukemia
  • NGS testing
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
Nov 18, 2022

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cladribine, cytarabine,venetoclax
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 22, 2022

    B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Nov 1, 2022

    CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

    Recruiting
    • CAR
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2022

    Severe COVID-19 Infection in CLL or B-NHL Who Received

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
      • (no location specified)
      Apr 6, 2023

      Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Jul 10, 2023

      B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B-cell Non Hodgkin Lymphoma
      • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
      • Aurora, Colorado
        Children's Hospital Colorado
      Nov 9, 2022

      Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 20, 2023

      B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma Trial (Autologous Humanized CD19-Directed Chimeric

      Not yet recruiting
      • B Cell Acute Lymphoblastic Leukemia (B-ALL)
      • B Lineage Lymphoblastic Lymphoma
      • Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
      • (no location specified)
      Jul 27, 2022

      Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

      Completed
      • Lymphoid Leukemia
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Jan 30, 2023

      Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 5, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

      Recruiting
      • B-cell Chronic Lymphocytic Leukemia
      • +3 more
      • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
      • +5 more
      • Duarte, California
      • +12 more
      Jun 16, 2022

      Tisagenlecleucel in Brazilian Acute Lymphoblastic Leukemia or

      Not yet recruiting
      • Diffuse Large B-cell Lymphoma
      • Acute Lymphoblastic Leukemia
      • tisagenlecleucel
      • (no location specified)
      Sep 13, 2022

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +5 more
      • (no location specified)
      Jul 21, 2023

      People Living With HIV Treated With CD19-directed CAR T Cell

      Active, not recruiting
      • Leukemia
      • +9 more
        • Philadelphia, Pennsylvania
          Pennsylvania Hospital
        Mar 29, 2023

        B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

        Not yet recruiting
        • B-cell Non Hodgkin Lymphoma
        • Chronic Lymphocytic Leukemia
        • Cyclophosphamide injection
        • +2 more
        • Charleston, South Carolina
          Hollings Cancer Center at Medical University of South Carolina
        Jan 18, 2023

        Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

        Not yet recruiting
        • Aggressive B-Cell Non-Hodgkin's Lymphoma
        • +4 more
        • (no location specified)
        Dec 16, 2022